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ABSTRACT 
The purpose of this work is to present an introduction and general overview on process validation of pharmaceutical manufacturing process especially tablet 
manufacturing process. Validation is the documented act of demonstrating that a procedure, process, and activity will consistently lead to the expected results. 
This type of validation is based on the physics of compression. It often includes the qualification of systems and equipment. It is a requirement for good 
manufacturing practices and other regulatory requirements. A properly designed system will provide a high degree of assurance that every step, process, and 
change has been properly evaluated before its implementation. Testing a sample of a final product is not considered sufficient evidence that every product 
within a batch meets the required specification. Three consecutive batches of tablets shall be taken up for process validation. Based on the result of these three 
batches the conclusion is drawn and Batch Manufacturing Record can be written once the validation process is complete. 
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INTRODUCTION 
Validation is a concept that has been evolving continuously 
since its first formal appearance in the United States in 1978. 
The concept of validation has expanded through the years to 
encompass a wide range of activities from analytical methods 
used for the quality control of the drug substances and drug 
products  to  computerized  systems  for  clinical  trials.  
Validation  is  therefore  one  element  of  quality  assurance 
associated with a particular process, as the process differs so 
widely,  there  is  no  universal  approach  to  validation  and 
regulatory bodies such as FDA and EC who have developed 
general  non-mandatory  guide  lines.  Then  word  validation 
simply means, ‘assessment of validity’ or action of proving 
effectiveness’.  A  tablet  formula  is  validated  when  the 
stochastic  weight  variations  do not  determine  unacceptable 
variations  of  tablet  properties.
1    According  to  European 
community  for  medicinal  products,  validation  is  ‘action  of 
proving’, in accordance with the principles of GMP that any 
procedures, process, requirement, material, activity or system 
actually leads to expected results.  
General Concept  
The concept of  validation was first proposed  by two Food 
and Drug Administration (FDA) officials, Ted Byers and Bud 
Loftus, in the mid 1970’s in order to improve the quality of 
pharmaceuticals  (Agalloco  1995).
2  Assurance  of  product 
quality is derived from careful attention to number of factors 
including selection of quality parts and materials, adequate 
product and process design, control of the process, and in-
process and end product testing.  Due to the complexity of 
today’s medical products, routine end product testing alone 
often is not sufficient to assure product quality for several 
reasons.    Some  end-products  tests  have  limited  sensitivity. 
E.g.:-  In  some  cases,  where  end  product  testing  does  not 
several all variations that may  occur in the product, which 
may have an impact on safety and effectiveness, destructive 
testing is required to show that the manufacturing process is 
adequate.  
 
                                                             
 
 
The basic goals of QA are as follows 
Quality, safety, and effectiveness must be designed and built 
in to the product;  
Quality cannot be inspected or tested in the finished product; 
hence  each  step  of  the  manufacturing  process  must  be 
controlled  to  maximize  the  probability  that  the  finished 
product  meets  all  quality  and  design  specification.  Quality 
control is the part of GMP, it is concerned with the sampling 
specification,  testing  and  with  organization  documentation 
and release procedures.
3 
4 
WHY VALIDATION?  
·  It would not be  feasible to use the equipments without 
knowing whether it will produce the product we wanted 
or not.  
·  The  pharmaceutical  industry  uses  expensive  materials, 
sophisticated facilities & equipments and highly qualified 
personnel.  
·  The efficient use of these resources is necessary for the 
continued success of the industry.  The cost of product 
failures,  rejects,  reworks,  recalls,  complaints  are  the 
significant parts of the total production cost.  
·  Detailed study and control of the manufacturing process- 
validation is necessary if failure cost is to be reduced and 
productivity improved.
5  
The  pharmaceutical  industries  are  concerned  about 
validation because of the following reasons 
Assurance of quality  
Without validation, a process that is well understood and in a 
state  the  confidence,  control  of  quality  of  the  product 
manufactured cannot be assured without validation  
Cost reduction  
Since  each  and  every  step  in  validation  is  monitored 
constantly there lesser rejects and reworks which would lead 
to an effective cost reduction. 
Government regulation  
Validation  is  considered  to  be  an  integral  part  of  GMPs. 
Worldwide  compliance  with  validation  requirements  is 
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necessary  for  obtaining  approval  to  manufacture  and  to 
introduce new products.  
The FDAs  cGMP refer to the concepts of the validation in 
both  sections.   211.110 & 211.113.  
Section 211.110 states that, such control procedures shall be 
established  to  monitor  the  output  and  to  validate  the 
performance of those manufacturing processes that may  be 
responsible for causing variability in the characteristics of in 
process  materials  and  drug  product.
6  The  accuracy, 
sensitivity,  specificity  and  reproducibility  of  test  methods 
employed   by the firm shall be established and documented.       
HOW VALIDATION IS DONE? 
The basic principle is characterized by harmony between the 
results obtained and requirements, which includes/supports. 
·  Specified requirements and objectives  
·  Available means  
·  Choices which are justified in relation to objectives  
·  Each stage should begin when the previous stage is over. 
Certain dispositions have to be taken into account as to 
Ø  How restrictions should be defined?  
Ø  How norms should be dealt with  
Ø  How modifications should be dealt with?  
    Controlling the evolution will involve 
Ø  Setting data for decision making  
Ø  Evaluation before decision making  
Ø  Justifying the decision  
Ø  Follow-up  
The following scheme may be suggested 
Ø  Aim versus objective  
Ø  Process as a whole and flow diagram  
Ø  Challenging the critical process variables  
Ø  Validation protocol  
Ø  Protocol  versus  report:  procedures,  sampling,  testing, 
reporting and results.  
Ø  Evaluation  and  recommendations  including  frequency 
for re validation. 
Responsible authorities for validation  
The validation working party is convened to define, instigate, 
progress,  collate,  coordinate  and  ultimately,  approve  the 
entire  effort,  including  all  of  the  documentation  generated.  
The working party would usually include the following staff 
members,  preferably  those  with  a  good  insight  into  the 
company’s operation.  
·  Head of quality assurance  
·  Head of engineering  
·  Validation manager  
·  Production manager  
·  Specialist validation discipline (s)-all areas 
TYPES OF VALIDATION 
Analytical validation  
Analytical  validation  is  the  evaluation  of  product  quality 
attributes through testing, to demonstrate reliability is being 
maintained  throughout  the  product  life  cycle  and  that  the 
precision, accuracy, strength, purity and specification has not 
been compromised.  
Equipment validation  
Validation  of  equipments  is  known  as  qualification.  
Equipment  validation  is  divided  into  installation 
Qualification  (IQ),  Operational  Qualification  (OQ),  and 
Performance Qualification (PQ).  
An IQ documents specific static attributes of a facility or item 
to prove that the installation of the unit has been correctly 
                                                             
 
performed  and  that  the  installation  specifications  of  the 
manufacturer have been met.  After installation it must be 
ensured that the equipment can deliver operating ranges as 
specified in the purchase order.  This is called OQ.  The PQ’s 
are  concerned  with  proving  that  the  process  being 
investigated works as it is supposed to do.    
Process validation  
Process validation is “A documented program which provides 
a  high  degree  of  assurance  that  a  specific  process  will 
consistently  produce  a  product  meeting  its  predetermined 
specification  and  quality  attributes”.  Process  validation 
should result in fewer product recalls and trouble shooting 
.process  consistently  under  control  requires  less  process 
support, will have less down time, fewer batch failures, and 
may  operate  more  efficiently  with  greater  output.
7  Process 
validation is divided into different types as follows 
Prospective validation 
It  is  defined  as  the  establishment  of  documented  evidence 
that  a  system  does  what  it  purports  to  do  based  on  pre-
planned protocol.  This validation is usually carried out prior 
to  the  introduction  of  new  drugs  and  their  manufacturing 
process.   
This approach to validation is normally undertaken whenever 
a new formula, process or facility must be validated before 
routine pharmaceutical formulation commences.   
Retrospective validation  
It  is  defined  as  the  establishment  of  documented  evidence 
that a system does what it purports to do based on review and 
analysis of historical data.  This is achieved by the review of 
the  historical  manufacturing  testing  data  to  prove  that  the 
process has always remained in control.   
Concurrent validation  
It is similar to prospective, except the operating firm will sell 
the product   during the qualification runs, to the public at its 
market  price.    This  validation  involves  in  process  
monitoring of critical processing steps and product testing.  
Revalidation 
It is the repetition of a validation process or a specific part of 
it.This is carried out when there is any change or replacement 
in formulation, equipment, plant or site location, batch size 
and in the case of sequential batches that do not meet product 
and process specifications. 
8 
Computer system validation 
Computer validation encompasses computers, which directly 
control  process  or  system  or  collect  analytical  data.  
Computer validation includes the qualification of all software 
and hardware, which has an impact, direct or indirect, on the 
quality  of  a  product.  The  validation  approach  to 
programmable logic controller (PLC) hardware and personal 
computers (PCs) is similar, both to one another and to the 
general overall approach top validation, in that the end user 
should define each requirement.
9  
PHASES OF VALIDATION 
Design Qualification (DQ)  
Document  verification  of  the  design  of  equipment  and 
manufacturing facilities. 
Installation Qualification (IQ) 
Documented verification of equipment of system design and 
adherence to manufacturer’s recommendations.  
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Operational qualification (OQ) 
Documented  verification  of  equipment  or  system 
performance in the target   operating range.  
Process performance qualification (PQ) 
Documented verification that equipment or systems operate 
as  expected  under  routine  productions  the  operation  is 
reproducible, reliable and in a state of control.  
PHASES IN PROCESS VALIDATION 
The activities relating to validation studies may be classified 
into three: 
Phase1 
This is the Pre-validation Qualification Phase which covers 
all activities  relating to product research and development, 
formulation pilot batch studies, scale-up studies, transfer of 
technology to commercial scale batches, establishing stability 
conditions  and  storage,  and  handling  of  in-process  and 
finished  dosage  forms,  equipment  qualification,  installation 
qualification  master  production  document,  operational 
qualification and process capacity.  
Phase 2 
This is the process validation phase.  It is designed to verify 
that all established limits of the critical process parameter are 
valid and that  satisfactory.  Products  can  be  produced  even 
under the worst conditions.  
Phase 3 
Known  as  the  validation  maintenance  Phase,  it  requires 
frequent review of all process related documents, including 
validation of audit reports, to assure that there have been no 
changes,  deviations  failures  and  modifications  to  the 
production  process  and  that  all  standard  crepitating 
procedures  (SOPs),  including  change  control  procedures, 
have  been  followed.    At  this  stage,  the  validation  team 
comprising of individuals representing all major departments 
also assures that there have been no changes/deviations that 
should have resulted in requalification and revalidation.  A 
careful design and validation of systems and process controls 
can  establish  a  high  degree  of  confidence  that  all  lots  or 
batches produced will meet their intended specifications.  It is 
assumed  that  throughout  manufacturing  and  control, 
operations are conducted in accordance with the principle of 
good manufacturing practice (GMP) both in general and in 
specific reference to sterile product manufacture.  
10   
VALIDATION PROTOCOLS  
Protocols should specify the following in detail  
· General information  
· Objective  
· Background/revalidation  
· Summary of development and technical transfer (form R& 
D  or  another  site  activity  to  justify  in  process  testing  and 
controls:  any  previous  validations.  Before  formal  cleaning 
validation programs were instituted, visual inspection was the 
primary means of determining equipment cleanliness.
11 
· List of equipments and their qualification status  
· Facilities qualification 
· Process flow chart  
· Manufacturing procedure narrative  
· List of critical processing parameters and critical excipients   
· Sampling, test and specification  
· Acceptance criteria 
 
                                                             
 
 
 
STRATEGY FOR VALIDATION OF METHODS 
The validity of a specific method should be demonstrated in 
laboratory experiments using samples or standards that are 
similar to the unknown samples analyzed in the routine.  The 
preparation and execution should follow a validation protocol 
preferably  written  in  a  step-by-step  instruction  format  as 
follows.  
·  Develop a validation protocol or operating procedure for 
the validation  
·  Define the application purpose and scope of the method;  
·  Define  the  performance  parameters  and  acceptance 
criteria  
·  Define validation experiments  
·  Verify  relevant  performance  characteristics  of  the 
equipment 
·  Select quality materials, e.g. standards and reagents;  
·  Perform pre-validation experiments;  
·  Adjust  method  parameters and/or  acceptance  criteria, if 
necessary;  
·  Perform  full  internal  (and  external)  validation 
experiments;  
·  Develop SOPs, for executing the method routinely; 
12 
·  Define criteria for revalidation  
·  Define  type  and  frequency  of  system  suitability  tests 
and/or  analytical  quality  control  (AQC)  checks  for  the 
routine; and  
·  Document  validation  experiments  and  results  in  the 
validation report.   
CRITICAL FACTORS AND SAMPLE THIEF 
Critical  factors  which  affect  conducting  effective  process 
validation  
·  The  quality  system  (infrastructure)  should  support  the 
validation effort by way of document control, calibration, 
preventive maintenance, etc.  
·  All  the  critical  points  of  the  process  should  be  clearly 
identified  
·  The process should run using the extremes of the system 
at the critical points (worst case).  
·  Adequate  run  (data)  are  required  to  provide  statistical 
support to demonstrate product consistency.  
·  The  execution  of  the  protocol  should  follow  the 
requirements  of  the  validation  document,  where  all 
deviations  form  the  validation  document  well  recorded 
and followed up properly.  
·  Before approving validation the area should be conformed 
for the requirement of validation. 
SAMPLE THIEF  
A significant improvement in sampling can be achieved with 
the use of sample thief, sometimes known as a grain thief of 
historical reasons. This device consists of 2 tubes one fitting 
tightly inside the other and with oolong holes cut through the 
tubes in corresponding positions. One end of the outer tube is 
fitted to a point to facilitate is insertion in to a bulk powder, 
the sampling procedure consists of rotating the inner tube to 
close the holes, inserting the device into the powder, rotating 
the inner tube to open the holes, allowing the powder to enter 
the  device,  rotating  the  inner  tube  once  more  to  close  the 
wholes and finally removing the thief from the bulk powder. 
The thief sampling is better method than merely scoping off 
the  top  of  a  bulk  powder,  it  is  still  an  inferior  technique.  
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Even  through  most  thieves  have  relatively  sharp  ends;  the 
very act of plunging the thief through the bulk powder must 
perturb  the  sample  to  some  degree.    A  compression  force 
propagates ahead of the thief as it is pressed into the bulk, 
thus potentially changing the strata of the bulk and altering 
the wall of powder at the outer walls of the thief.  Further 
more, because large particles will flow more easily than will 
small  particles,  an  opened  thief  is  liable  to  be  filled 
preferentially  with  the  coarse  fraction  of  the  particle 
distribution. 
13 
Operation of sample Thief  
a.  The  sleeve  rotates  so  that  the  interior  compartment  is 
isolated  form  the  bulk  powder,  while  in  the  closed 
position, the thief is plunged into the central mass of the 
powder.  
b.  Once the thief is at the desired position, the unit is rotated 
so that the interior compartment is now  exposed to the 
bulk powder.  Powder flows into the thief compartment of 
its own accord.  
c.  Once the interior compartment of the thief is filled, the 
sleeve  of  the  thief  is  rotated  so  that  the  interior 
compartment is again isolated from the bulk powder.  The 
thief is then withdrawn form the powder, and the sample 
is analyzed. 
14   
GENERAL NOTES 
PROCESS VARIATIONS 
The following are the sources, which may lead to variations 
in manufacturing operations. Variations are possible in 
Materials (Raw material and packing components) 
· Different suppliers of the same material  
· Different batches form the same supplier   
Equipment and facilities  
· Different equipments for the same process  
· Difference in adjustment of equipments 
· Inadequate operating conditions  
· Alternate equipments for the same process  
Procedures  
· Not clear and specific  
· Inadequate  
· Negligence by chance  
Personnel  
· Inadequate training and understanding  
· Lack of interest  
· Dishonesty, fatigue, carelessness  
· Poor communication and co-operation  
Instrument calibration  
A pharmaceutical operation uses many measuring devices to 
control  the  process.    An  operator  accomplishes  either 
automatically  by  an  appropriate  feed  back  mechanism  or 
through manual adjustment in this control.   In either case 
proper validation of the measuring device is critical to the 
process.    Some  device  that  may  require  calibration  are 
thermometer,  pressure  gauges,  relative  humidity  meters, 
conductivity  meters,  timers,  alarms  etc.  similarly  some 
laboratory  instruments  that  need  calibration  are  balances, 
spectrophotometers, chromatography, computers, PH meters 
and rhymesters etc.
15  Thus calibration is carried out early in 
the validation program.  The specification and frequency of 
                                                             
 
 
 
calibration  must  be  related  to  the  use  of  the  device  or 
instrument in context of the overall process.   
Critical support system  
A support system is any general system that the plant needs 
to  operate  daily.    These  include  air-handling  system, 
electrical networks, vacuum for cleaning, water supply and 
others.  For the purpose of validation we are concerned with 
the critical support system.  These are the systems that must 
operate at a certain level in order to maintain the required 
level of quality of the final product. The qualifications of a 
critical plant support system consist of three phases viz. The 
first  phase  is  designing  a  system  or  defining  an  existing 
system.  The second is making sure that the installed system 
performs as designed if possible, challenging the system to 
make  sure  that  normal  and  reasonable  inputs,  the  system 
output acceptable.   
Operator qualification 
The  operator  is  the  most  important  element  in  a  process.  
Thus  the  qualification  of  the  operator  by  training  and 
experience is absolutely essential to the success of the whole 
validation program.  An untrained operator can neglect the 
work done in qualifying the other components of the process.  
The  qualified  operator  is  trained  in  all  aspects  of  the  job, 
technical, supervisory, productivity, GMP etc. 
Raw material and packing material  
Qualification of material involves the testing of specification 
for  all  critical  parameters  of  the  materials.    These 
specifications must be set in the light for their purpose the 
end use of the product.  Frequently the material will have 
specification  in  addition  to  those  found  in  an  official 
pharmacopoeia,  such  as  particle  size  specification  for  an 
ingredient in table formulation.   Importantly vendor must be 
qualified.    Vendor  qualification  usually  includes  testing  of 
samples and an audit of the vendor facility.   
Equipment  
The qualification of the equipment starts with the design or 
selection  process,  followed  by  installation  and  verification 
that the equipment functions are desired.  Qualification of the 
equipment  also  requires  the  development  of  written 
procedures  that  describe  the  proper  operation  of  the 
instrument/equipment,  the  development,  preventive 
maintenance program, the validation of cleaning procedure, 
and the training of personnel using or supervising the use of 
equipment.  Cleaning procedure must be adequate to remove 
product  or  dirt leaving  acceptable  (low)  levels  of  cleaning 
agents,  solvents  etc.  if  the  equipment  must  be  sterile  or 
progeny  free the procedures to accomplish this have to  be 
shown to be effective   
Facilities  
The qualification of the facility includes four phase-designs, 
construction,  verification  and  on  going  maintenance  and 
monitoring.  At the design or planning phase, the purpose of 
the  facility,  the  products  to  be  manufactured,  cGMP  and 
efficiency requirements, as well as cost must be considered.  
The design of the critical system is most important.  Flow of 
the material and personnel to avoid contamination has to be 
studied.  Room surface especially in aseptic areas; have to be 
designed for effective sanitation. Finally everything needs to 
be  documented.    The  constriction  phase  requires  careful 
supervision to make sure that all design specification is being 
met.  The process of verifying that the construction facility 
meets  all  established  requirements  stars  when  construction 
commences and ends with the installation and qualification of 
the equipment and critical systems.  Chawla Nirmaljot Singh et al. IRJP 2012, 3 (1) 
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Qualification of manufacturing stage  
For  each  type  of  pharmaceutical  dosage  form  there  are 
various  stages  in  manufacturing  process  that  need  to  be 
qualified in order to validate the complete process.  
Product design  
The  product  design  consists  of  the  formulation, 
container/closure system, basic manufacturing procedure and 
quality  control  specification  and  methodology, 
chronologically;  product  design  is  the  first  elements  of 
validation to be studied.  Although product development is 
normally the responsibility of the R&D function, it is wise to 
involve plant personnel since their experience and knowledge 
of  the  plant  capabilities  can  be  very  valuable.    A  poorly 
designed  product  can  make  it  impossible  to  validate  and 
control a process.  It is important to emphasize the necessity 
of  not  making  changes  in  a  validated  process  without 
considering the consequences of the change, such as the need 
to be validating the process if the change is significant, the 
more  frequently  the  problems  and  failures  that  occur  are 
caused  by  changes  made  in  a  thoroughly  studied  and 
validated system.
16  
APPROACHES TO VALIDATION PROCESS 
There  are  two  basic  approaches  to  the  validation  of  the 
process itself (apart from the qualification of equipment used 
in  production,  the  calibration  of  control  and  measurement 
instruments,  the  evaluation  of  environmental  factors  etc). 
These are the experimental approach, which is applicable to 
both prospective and concurrent validation, may involve.  
·  Extensive product testing 
·  Simulation process trials,  
·  Challenge/worst  case  trials,  and  control  of  process 
parameters. 
One of the most practical forms of process validation, mainly 
for non-sterile products, is the final testing of the product to 
the extent greater than that required in routine quality control.  
It may involve extensive sampling far beyond that called for 
in  routine  quality  control  and  specifications,  and  often  for 
certain parameters only.  Thus for instance, several hundred 
tablets  per  batch  may  be  weighed  to  determine  unit  dose 
uniformity.  The results are then treated statistically to verify 
the  normality  of  the  distribution  and  to  determine  the 
standard  deviation  from  the  average  weight.    Confidence 
limits for individual results and for batch homogeneity are 
also  estimated.    Strong  assurance  is  provided  that  samples 
taken  at  random  will  meet  regulatory  requirements  if  the 
confidence  limits  are  within  compendia  specifications.
17  In 
the  approach  based  on  analysis  of  historical  data,  no 
experiments  are  performed  in  retrospective  validation,  but 
instead all available historical data concerning a number of 
batches are combined and jointly analyzed, if production is 
proceeding smoothly during the period preceding validation 
and  the  data in  process  inspection  and  final  testing  of  the 
product  are  combined  and  treated  statistically.  The  restful 
including  the  outcome  of  process  capability  studies,  trend 
analysis,  etc.,  will  indicate  whether  the  process  is  under 
control or not.   
THE VALIDATION REPORT 
A written report should be available after completion of the 
validation.  If found acceptable, it should be approved and 
                                                             
 
 
authorized (signed and dated). 
18 The report should include at 
least the following.  
·  Title and objective of study 
·  Reference to protocol 
·  Details of material  
·  Equipment  
·  Programs and cycles used 
·  Details of procedures and test methods.  
·  Result (compared with acceptance criteria), and  
·  Recommendations on the limit and criteria to be applied 
on future basis.
19 
20 
CONCLUSION 
Based on the obtained data and dissolution data from all three 
consecutive lots of first validation batch and finished product 
analytical  data  of  all  three  validation  batches,  it  can  be 
concluded that process of manufacturing stands validated. So 
it  is  recommended  to  follow  the  same  for  forth  coming 
batches 
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CONTROL PARAMETERS FOR CONSIDERATION IN SOLID DOSAGE FORMS DEVELOPMENT 
UNIT OPERATION  PROCESS VARIABLE   
METHOD RESPONSES 
Dry mixing  Mixing time  Power consumption. 
Granulation 
Load, speed, binder 
Addition rate, 
Granulation time, Amperage 
Reading of impeller & chopper 
Power consumption. 
 
Drying  Load, inlet temperature, 
Air flow rate, drying time. 
Moisture Content 
/LOD 
Blending(mixing)  Load, speed, mixing time  Blend uniformity. 
 
Compression 
Press speed, feed rate, 
precompression force, 
Compression force. 
Tablet weight, moisture 
content, hardness, thickness, 
dissolution, disintegration, 
Content uniformity. 
 
PROTOCOL FOR PROCESS VALIDATION OF SOLID DOSAGE FORMS (TABLETS) PROCESS OVER VIEW 
 
 
For sampling of homogenous liquid and thin emulsion generally use dipper bottle 
 
 
Department /Designation  Responsibility 
Manager-Production  Responsible for manufacturing of batches and review of protocol and report. 
Manager – QC  Responsible for analysis of samples collected 
Executive QC-  Responsible for samples collection and submission to QC 
Manager-Maintenance  Providing utilities and engineering support 
Executive – Production  Responsible for preparation of protocol and manufacturing of validation batches 
Manager –QA  Responsible for protocol authorization and preparation of summary report. 
 